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Statistical	   association	   studies	   have	   contributed	   significantly	   in	   the	   detection	   of	   novel	   genetic	   factors	  
associated	   with	   complex	   diseases.	   However,	   there	   are	   various	   challenges	   in	   solving	   the	   missing	  
heritability	   issue	   solely	   depending	   on	   statistical	   evidence	   of	   the	   association	   between	   genotype	   and	  
phenotype,	   especially	   for	   sequencing	   data.	   Incorporation	   of	   biological	   information	   that	   reflects	   the	  
complex	  mechanism	  of	  disease	  development	   is	   likely	   to	   increase	   the	  power	  of	   association	   studies	   for	  
detecting	  novel	  disease	  genes.	  In	  this	  study,	  we	  develop	  a	  statistical	  framework	  for	  association	  studies	  
that	   integrates	   the	   information	  of	   the	   functional	  effect	  of	  SNPs	   to	   the	  disease	   related	  protein-­‐protein	  
interactions.	  The	  method	   is	  applied	   to	  GAW19	  exome	  sequencing	  data	  of	  uncorrelated	   individuals	   for	  
detecting	  novel	  genes	  associated	  to	  hypotension.	  Based	  on	  both	  the	  real	  and	  simulated	  phenotypes	  of	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Chapter  1:  Introduction    
Statistical	   association	   studies	   serve	   an	   important	   role	   in	   finding	  putative	   disease	   genes	   for	   further	   biological	  
validation	  and	   reasoning.	  There	  are	  many	  association	  methods,	  but	   the	  common	  essential	   idea	   is	   to	   test	   the	  
strength	  of	  statistical	  evidence	  for	  abnormal	  /	  non-­‐random	  mutation	  distribution	  in	  cases	  and	  in	  controls.	  Such	  
statistical	  evidence	  won’t	  be	  strong	  or	  reliable	  if	  data	  sample	  size	  is	  relatively	  small	  and/or	  SNP	  mutations	  are	  
rare,	   often	   the	   challenges	   imposed	   in	   current	   sequencing	   studies.	   Furthermore,	   the	   mechanism	   of	   genetic	  
effect	  is	  complex,	  not	  a	  straight	  line	  from	  DNA	  to	  disease.	  A	  gene	  may	  be	  critical	  to	  a	  disease	  pathway,	  but	  the	  
final	  disease	   status	  are	  affected	  by	  many	  other	   factors	   so	   that	   the	  association	  evidence	  measured	  strictly	  by	  
genotype	  and	  phenotype	  data	  could	  also	  be	  weak.	  This	  is	  the	  challenge	  for	  finding	  more	  subtle	  disease	  genes	  to	  
explain	   the	  missing	  heritability,	   especially	   after	   the	   low-­‐hanging	   fruits	  have	  been	  picked.	   In	  order	   to	  address	  
these	  challenges	  and	  increase	  the	  statistical	  power	  of	  association	  studies,	  it	  is	  promising	  to	  properly	  integrate	  
biological	  prior	   information	  of	  the	  variants	  that	  reflect	  the	  middle	  steps	  of	  the	  genetic	  mechanism	  to	  disease	  
development	  process.	  	  
In	   this	   study,	   we	   develop	   a	   statistical	   framework	   that	   allows	   incorporating	   prior	   information	   of	   SNPs	   into	  
association	  tests.	  The	  basic	  idea	  is	  to	  prioritize	  SNPs	  that	  show	  prior	  importance	  to	  disease	  development.	  This	  is	  
realized	  by	  relatively	  weighting	  the	  genotype	  of	  SNPs	  according	  to	  their	  prior	  information	  in	  testing	  a	  SNP	  set,	  
which	  is	  treated	  as	  the	  functional	  unit	  of	  association,	  e.g.,	  a	  gene.	  This	  framework	  has	  two	  major	  components.	  
First,	  SNP	  weights	  are	  properly	  generated	  based	  on	  their	  functional	  annotation.	  Second,	  a	  likelihood	  ratio	  test	  
(LRT)	   is	   constructed	   to	   incorporate	   these	   weights.	   To	   detect	   the	   presence	   of	   disease	   SNPs	   in	   a	   gene,	   LRT	  
statistic	   is	   the	   ratio	   of	   the	   likelihoods	   between	   the	   null	   and	   the	   alternative	   regarding	   to	   whether	   the	  
distribution	   in	  cases	  differ	  that	   in	  controls.	  Thus	  LRT	   is	   flexible	  to	  construct	  according	  to	  the	  meanings	  of	  the	  
null	  of	  no	  association	  and	  the	  alternative	  while	  incorporating	  informative	  weights.	  Furthermore,	  LRT	  is	  optimal	  
for	  detecting	  weak	  and	  sparse	  signals	  {Ingster,	  1997	  #2436;Yang,	  2014	  #2444}.	  	  There	  are	  different	  versions	  of	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LRT,	  but	  we	  adapt	  a	   formulation	  by	  Chen	  et	  al.	   {Chen,	  2013	  #2486}	  as	   the	  prototype	  statistic	   for	   sequencing	  
data.	  	  
Protein-­‐protein	  interactions	  (PPI)	  are	  one	  important	  component	  related	  to	  disease	  development.	  Disease	  gene	  
may	  function	  through	  influencing	  PPIs.	  Several	  recent	  genome-­‐wide	  association	  studies	  (GWAS)	  have	  reported	  
the	  value	  of	   incorporating	  PPI	   information	  into	  the	  pipeline	  of	   identifying	  novel	  genes	  of	  Type	  1	  diabetes	  and	  
kidney	  dysfunction	   {Bergholdt,	  2012	  #2484;Chasman,	  2012	  #2487}.	  However,	   their	  methodology	  mainly	  uses	  
generic	  functional	  information,	  e.g.,	  GO	  terms,	  to	  filter	  candidate	  genes	  and	  SNPs	  for	  test,	  but	  the	  association	  
test	  itself	  is	  traditional	  without	  incorporating	  such	  information	  {Consortium,	  2007	  #2909}.	  Filtering	  will	  loosen	  
the	  strict	  genome-­‐wide	  significance	  level	  in	  favour	  of	  relatively	  weak	  association	  signals	  of	  true	  functional	  SNPs	  
and	  genes,	  but	  it	  would	  be	  nicer	  to	  drop	  as	  few	  genes	  as	  possible,	  and	  combine	  the	  prior	  biological	  information	  
with	  association	  test	  process	  in	  a	  quantitative	  fashion.	  In	  this	  study,	  we	  predict	  and	  annotate	  the	  effect	  of	  SNPs	  
to	   disease	   related	   PPIs.	   Then	   we	   convert	   the	   annotation	   into	   a	   component	   of	   SNP	   weighting	   scheme	   for	  
incorporating	  into	  the	  LRT	  test.	  The	  purpose	  is	  not	  to	  restrict	  the	  gene	  candidates	  but	  to	  use	  PPI	  information	  to	  
improve	  the	  ranking	  profile	  of	  all	  genes.	  
	  
Chapter  2:  Methodology    
Research  design  
To	   implicitly	   incorporate	  the	  PPI	   information	  for	  aiding	  gene	  hunting,	  we	  estimate	  and	  employ	  the	  weighting	  
scheme	  of	  variants	  according	  to	  their	  effects	  on	  PPIs	  and	  study	  their	  group	  association	  by	  using	  a	  flexible	  LRT	  
testing	  procedure.	  Figure	  1	  shows	  the	  workflow	  of	  four	  steps	  to	  achieve	  the	  goal.	  First,	  we	  determine	  the	  seed	  
genes	  associated	  with	  Hypertension	  based	  on	  literature,	  data	  evidence	  and	  other	  related	  sources	  (Welter,	  D.	  et	  
al,	  2014;	  Online	  Mendelian	  Inheritance	  in	  Man,	  OMIM).	  Second,	  we	  analyse	  PPI	  network	  (physical	  interactions	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only)	  centering	  on	  these	  seed	  genes	  to	  find	  out	  candidate	  genes	  associated	  with	  Hypertension.	  The	  candidate	  
genes	  will	   be	  utilized	   to	   study	   the	   statistical	   association	  with	  Hypertension	   (Szklarczyk,	  Damian,	   et	   al,	   2011).	  
Third,	  we	  create	  annotations	  for	  SNPs	  regarding	  their	  impact	  on	  the	  several	  aspects	  of	  PPI	  networks.	  Fourth,	  we	  
incorporate	  the	  SNP	  annotation	  information	  (weighting	  score)	  into	  the	  statistical	  association	  study	  by	  the	  LRT	  
test.	  In	  the	  following,	  we	  give	  details	  of	  each	  step.	  	  
Seed  gene  detection  
The	   “seed	   genes”	   are	   obtained	   from	  OMIM	   (Online	  Mendelian	   Inheritance	   in	  Man)	   by	   1)	   Searching	   the	   key	  
word:	  hypertension	  OR	   (("high	  blood	  pressure")),	   and	  2)	   Extracting	  only	   genes	  with	  direct	   “phenotype-­‐	   gene	  
relationships”.	   The	   original	   gene	   list	   from	   step	   (1)	   yielded	   290	   genes.	   Step	   (2)	   is	   performed	   by	   manually	  
justifying	  each	  gene	  and	   taking	  only	   the	  entries	  with	  “phenotype-­‐gene	   relationship”	   recorded	  on	  OMIM.	  See	  
result	  section	  for	  a	  list	  of	  21	  genes	  that	  was	  obtained	  as	  the	  final	  seed	  genes.	  
Candidate  gene  detection    
The	  “candidate	  genes”	  are	  obtained	  from	  multiple	  sources.	  First,	  HINT	  (High-­‐quality	  INTeractomes)	  from	  Yulab,	  
is	  a	  database	  containing	  high-­‐quality	  PPIs,	  which	  are	  complied	  from	  various	  sources.	   It	   takes	  gene(s)	  as	   input	  
and	   output	   an	   interactive	   image	   of	   its	   PPI	   network.	  We	   input	   seed	   genes	   into	   HINT,	   select	   interaction	   type	  
“Binary”/	  “co-­‐complex”	  respectively,	  and	  enable	  the	  high-­‐quality	  filter	  to	  obtain	  only	  high-­‐quality	  interactomes.	  
The	   genes	   in	   the	   PPI	   network	   are	   considered	   as	   candidate	   genes.	   	   [See	   the	   figure	   for	   seed	   genes	   and	   their	  
neighbourhood	  genes.]	  
Second,	  Human	   Interactome	  Database	   (http://interactome.dfci.harvard.edu/index.php?page=home)	   is	   part	  
of	   the	   CCSB	   project,	   which	   takes	   efforts	   to	   map	   the	   human	   binary	   interactome.	   Their	   long-­‐term	   goal	   is	   to	  
generate	   and	   analyze	   high-­‐quality	   yeast	   two-­‐hybrid	   (Y2H)	   interactions	   at	   high-­‐throughput	   for	   all	   pairwise	  
combinations	  of	  predicted	  gene	  products	  for	  which	  there	  is	  at	  least	  one	  Gateway-­‐cloned	  ORF	  available	  (Human	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ORFeome	  website).	  All	   individual	  datasets,	   including	  our	  most	   recent	  unpublished	  data,	   are	  described	  below	  
with	  hyperlinks	  to	  the	  prepublication	  data	  or	  the	  relevant	  publications.	  
Third,	   the	  association	  Test	  C(α)	  enables	   the	   test	   for	   rare	   variants	  disease	  association,	  under	   the	  assumption	  
that	  the	  rare	  variants	  in	  cases	  and	  controls	  are	  a	  mix	  of	  deleterious,	  protective	  and	  neutral	  variants.	  The	  C(α)	  
statistic	  is	  computed	  as	  follows:	  
T =    [!!!! (𝑦! −   𝑛!𝑝!)! −   𝑛!𝑝!(1 − 𝑝!)]	  
The	   C(α)	   test	   would	   yield	   a	   list	   of	   variants	   with	   considerably	   low	   p-­‐values,	   which	   could	   be	   considered	   as	  
candidate	  genes.	  The	  cut-­‐off	  of	  p-­‐value	  for	  C	  (α)	  test	  is	  set	  to	  0.001.	  
Fourth,	  the	  association	  test	  CMC	  (Combined	  and	  Multivariate	  Collapsing	  method	  for	  rare	  variants)	  tests	  for	  rare	  
variants	  disease	  association	  as	  well.	  CMC	  method	  groups	  variants	  by	  gene.	  The	  CMC	  method	  uses	  Fisher’s	  test	  
statistic	   to	   avoid	   the	   computationally	   intensive	   permutation	   procedure.	   The	   input	   would	   be	   our	   raw	   data.	  
Output	  variants	  with	  low	  p-­‐values	  would	  be	  considered	  as	  candidate	  genes.	  The	  cut-­‐off	  of	  p-­‐value	  for	  CMC	  test	  
is	  set	  to	  0.002.	  	  
Annotate  nsSNVs  according  to  protein  binding  sites    
We	  annotated	  non-­‐synonymous	  SNVs	  by	  sequence-­‐based	  prediction	  on	  whether	  they	  locate	  in	  protein	  binding	  
sites.	   In	   particular,	   based	   on	   the	   variant	   information	   provided	   in	   the	   VCF	   files	   of	   the	   odd	   numbers	   of	  
chromosomes	  for	  uncorrelated	  individuals,	  applying	  ANNOVAR	  [citation],	  we	  annotated	  4,457	  nsSNVs	  on	  2,711	  
genes	  regarding	  to	  whether	  they	  are	  located	  on	  protein	  binding	  sites	  or	  not.	  	  
Likelihood  ratio  tests  (LRT)    
For	  a	  gene	  𝑔! 	  (or	  a	  functional	  group	  of	  SNP	  set),	  the	  generic	  LRT	  formula	  is	  	  Λ 𝑔! = log 𝐿!𝐿! 𝐿 ,	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  (1)	  
7	  
	  
where	  𝐿!,	  𝐿!,	  and	  𝐿	  are	  the	  likelihoods	  for	  the	  distributions	  of	  an	  appropriate	  disease-­‐association	  measure	  in	  
cases,	  in	  controls,	  and	  in	  both	  groups.	  The	  numerator	  of	  LRT	  separates	  the	  likelihoods	  in	  cases	  and	  in	  controls	  
to	  model	  the	  alternative	  hypothesis	  that	  there	  exists	  an	  association	  in	  terms	  of	  the	  differentiation	  between	  the	  
two	   groups;	   the	   denominator	   pools	   the	   data	   of	   cases	   and	   controls	   together	   for	   the	   likelihood	   of	   the	   null	  
hypothesis	  of	  no	  association.	  Here	  we	  adapt	  an	  LRT	  based	  on	  Bernoulli	  likelihoods	  {Chen,	  2013	  #2486}:	  	  
Λ 𝑔! = log !!! !!!(!!!!!)(!!!!!) !!! !!!(!!!!!)(!!!!!)!! !! !!!! (!!!!!!) ,	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  (2)	  
where	  𝑚	  and	  𝑙	  are	  the	  number	  of	  cases	  and	  controls,	  𝑇!!,	  𝑇!!	  and	  𝑇! 	  (𝑝!!,	  𝑝!!	  and	  𝑝!)	  are	  the	  total	  numbers	  (and	  
the	  corresponding	  estimated	  proportions)	  of	  the	  burden	  scores	  that	  exceed	  a	  threshold	  𝑡	  in	  cases,	  controls	  and	  
both	  groups,	  respectively.	  	  
The	   burden	   scores	   are	   the	   collapsed	   genotypes	   over	   SNVs	   on	   a	   gene,	   which	  measure	   the	   overall	   mutation	  
distributions	  {Morgenthaler,	  2007	  #2847}.	  Specifically,	  for	  the	  jth	  gene	  of	  the	  individual	  k,	  the	  burden	  score	  is	  	  𝑆!" = 𝑥!"!!!!! ,	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  (3)	  
where	  𝑥!" 	  is	  the	  genotype	  of	  SNP	  𝑖	  of	  individual	  𝑘.	  We	  search	  a	  sequence	  of	  threshold	  𝑡	  and	  choose	  the	  value	  
that	  maximizes	  the	  test	  statistic.	  When	  𝑝!! 	  ≤	  𝑝!!,	  the	  test	  statistic	  is	  adjusted	  to	  be	  
Λ 𝑔! = log !!! !!!(!!!!!)(!!!!!) !!! !!!(!!!!!)(!!!!!)!! !! !!!! (!!!!!!) .	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  (4)	  
	  
We	   apply	   permutation-­‐based	   test	   to	   calculate	   p-­‐values,	  which	   accommodates	   the	   departure	   of	   assumptions	  
not	  necessarily	  satisfied	  in	  real	  data	  to	  control	  the	  type	  I	  error	  rate.	  We	  implemented	  the	  LRT	  and	  permutation	  
test	  by	  R	  functions,	  and	  applied	  Variant	  Tools	  {San	  Lucas,	  2012	  #2441;Wang,	  2014	  #2440}	  to	  manipulate	  data	  
and	  to	  call	  these	  R	  functions.  
LRT  for  burden  score  weighted  by  binding  site  information  (LRT-­‐BS)    
This	  modified	  LRT	  method	  similar	  as	  above	  but	  with	  a	  weighted	  burden	  score	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𝑆!" = 𝑠!𝑥!"!!!!! ,	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  (5)	  
where	  𝑠! 	  is	  the	  weight	  to	  indicate	  the	  importance	  of	  variants	  according	  to	  whether	  they	  are	  located	  on	  protein	  
binding	  sites.	  
Chapter  3:  Results  
Simulation  data  analysis  
GAW19	  exome	  sequencing	  variants	  on	  odd	  numbers	  of	  chromosomes	  for	  uncorrelated	  individuals	  are	  used	  as	  
the	   genotype	   data.	   Phenotypes	   are	   the	   hypertension	   status	   (about	   336	   cases	   and	   1,607controls)	   of	   the	   200	  
simulations.	  Using	  the	  simulated	  data,	  we	  can	  study	  the	  statistical	  power	  and	  type	   I	  error	  rate	  control	  of	   the	  
association	  tests.	  	  
First,	  we	   study	   the	   strategy	   to	  weight	   the	   functional	   SNVs.	   Figure	   1	   shows	   the	  power	   curves	   of	   three	   genes	  
containing	   simulated	   functional	  SNVs:	  SPTBN4	   (functional	  SNVs	  have	   relatively	   strong	  beneficial	  effects),	  TPR	  
(functional	  SNVs	  have	  relatively	  weak	  effects),	  and	  TCIRG1	  (functional	  SNVs	  have	  relatively	  strong	  deleterious	  
effects).	  We	  arbitrarily	   select	  10	   functional	  SNVs	  and	  assign	  weight	   (2,	  5	  or	  10),	   the	   rest	   functional	  SNVs	  are	  
pretended	  unknown,	  and	  they	  and	  the	  rest	  irrelevant	  SNVs	  are	  assigned	  weight	  (1	  or	  -­‐1).	  Figure	  1	  shows	  that	  
different	  weighting	   schemes	   perform	  differently,	   but	   in	   general	   the	   combination	   1-­‐10	   is	   relatively	   good	   and	  
robust.	   Thus,	   we	   assign	   potentially	   functional	   SNVs	   and	   the	   rest	   weights	   that	   have	   the	   same	   sign	   but	   with	  
relatively	  big	  difference.	  For	  the	  nsSNVs	  in	  binding	  site,	  we	  assign	  weight	  10;	  for	  nsSNVs	  on	  in	  binding	  site,	  we	  
assign	  weight	  5;	  and	  for	  the	  synonymous	  SNVs,	  we	  assign	  weight	  1.	  	  
	  
Second,	  we	  compare	  LRT	  and	  the	  LRT-­‐BS	  regarding	  to	  their	  statistical	  power	  and	  size.	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Real  data  analysis  
The	  phenotype	  data	  is	  based	  on	  the	  real	  DBP	  and	  SBP,	  for	  which	  hypertension	  cases	  are	  defined	  as	  individuals	  
with	  SBP>=140	  or	  DBP>=	  90	  according	  to	  the	  American	  Heart	  Association.	  Thus	  for	  the	  real	  data	  we	  have	  394	  
cases	  and	  1,457	  controls.	  	  
	  
Four	  methods	  are	  applied	  to	  the	  association	  tests	  for	  genes	  (RefGene):	  C-­‐α	  test	  {Neale,	  2011	  #2850},	  CMC	  test	  
{Li,	  2008	  #2822},	  LRT,	  and	  LRT-­‐BS.	  Table	  1	  shows	  the	  top	  genes	  (with	  p-­‐values	  	  <	  2.0E-­‐4)	  yielded	  by	  C-­‐α	  test	  (4	  
genes),	  CMC	  (3),	  LRT	  (5),	  LRT-­‐BS	  (8).	  At	  the	  same	  level	  of	  the	  genomic	  inflation	  factor	  λ,	  LRT-­‐BS	  has	  three	  more	  
genes	  discovered	  than	  LRT,	  which	  include	  gene	  MSL2,	  a	  gene	  also	  discovered	  by	  CMC	  with	  a	  good	  inflation	  level	  
of	  λ=1.03.	  Thus	  LRT-­‐BS	  is	  more	  powerful	  than	  LRT.	  	  
Chapter  4:  Discussions    
One	   of	   the	   limits	   of	   current	   method	   is	   that	   genomic	   inflation	   factor	   is	   relatively	   big,	   which	   needs	   further	  
research	  and	  modification.	  
The	  annotations	  for	  whether	  a	  SNV	  is	  on	  the	  binding	  site	  has	  limit	  in	  specifying	  the	  influence	  of	  the	  SNVs	  to	  the	  
protein-­‐protein	   interactions.	   Further	   annotations	   on	   the	   SNV	   effect	   (beneficial,	   deleterious,	   or	   neural)	   to	  
individual	   PPIs	   and	   the	   PPI	   network	   as	   a	   whole	   will	   provide	   more	   information.	   LRT	   has	   the	   potential	   to	  
incorporate	  different	   levels	  of	  the	   information	  by	  constructing	  multiple	  components	  of	  the	  test	  statistics.	  We	  
will	  test	  on	  this	  idea	  later	  as	  long	  as	  we	  get	  the	  improved	  estimation	  of	  the	  SNV	  effects.	  	  
Chapter  5:  Conclusions  and  Justification  
Biological	   information	  on	  SNVs	  can	  be	  used	  to	  improve	  the	  association	  tests.	  We	  incorporate	  the	  information	  
on	  whether	  nsSNVs	  are	  located	  in	  protein	  binding	  site	  into	  a	  LRT	  test,	  which	  has	  the	  similar	  genomic	  inflation	  
10	  
	  
factor	  as	  the	  original	  LRT	  test	  but	  provide	  more	  power	  to	  detect	  more	  significant	  genes.	  Among	  the	  putative	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Figures  
Figure  1    -­‐  Gene  detection  working  flow.  
Four	   steps	   are	   involved	   in	   gene	   detection.	   Two	   main	   components:	   Estimation	   of	   SNP	   annotations	   on	   their	  






Figure  2    -­‐  QQ-­‐plot  for  CMC,  C-­‐alpha,  LRT  methods  
	  






Table  1    -­‐  Seed  gene  list  
Top	  genes	  and	  their	  p-­‐values	  by	  four	  association	  tests	  (λ	  is	  the	  genomic	  inflation	  factor).	  	  
	  










7	   1.99E-­‐04	   -­‐	   -­‐	   -­‐	  
LUC7L2	   7	   1.99E-­‐04	   -­‐	   -­‐	   -­‐	  
DNAH9	   17	   1.99E-­‐04	   -­‐	   -­‐	   -­‐	  
AKAP8	   19	   1.99E-­‐04	   -­‐	   -­‐	   -­‐	  
MSL2	   3	   -­‐	   4.39E-­‐05	   -­‐	   <	  1.00E-­‐4	  
ZBTB4	   17	   -­‐	   9.21E-­‐05	   -­‐	   -­‐	  
BCHE	   3	   -­‐	   1.55E-­‐04	   -­‐	   -­‐	  
LZIC	   1	   -­‐	   -­‐	   <	  1.00E-­‐4	   <	  1.00E-­‐4	  
ABO	   9	   -­‐	   -­‐	   -­‐	   -­‐	  
COL15A1	   9	   -­‐	   -­‐	   <	  1.00E-­‐4	   <	  1.00E-­‐4	  
PSPC1	   13	   -­‐	   -­‐	   -­‐	   <	  1.00E-­‐4	  
TLN2	   15	   -­‐	   -­‐	   -­‐	   <	  1.00E-­‐4	  
ZNF557	   19	   -­‐	   -­‐	   -­‐	   <	  1.00E-­‐4	  
ITGA2	   5	   -­‐	   -­‐	   <	  1.00E-­‐4	   -­‐	  
ZMYM5	   13	   -­‐	   -­‐	   -­‐	   <	  1.00E-­‐4	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YIPF2	   19	   -­‐	   -­‐	   <	  1.00E-­‐4	   <	  1.00E-­‐4	  











#Note	  this	  function	  give	  the	  inversed	  direction	  weight,	  contrasting	  to	  weightBurdenTest.R	  
#######################################################	  
#Description:	   Interface	   R	   function	   to	   be	   called	   by	   Variant	   Associate	   Tools.	   It	   has	   the	   choice	   to	   calculate	   an	  
association	  test	  statistic	  based	  on	  direction	  weighted	  burden	  score.	  That	  is,	  if	  MAF	  in	  cases	  <	  MAF	  in	  controls,	  
direction	  weight	  =	  1,	  o.w.,	  =-­‐1.	  Further	  explicit	  weights	  can	  be	  multiplied	  by	  these	  direction	  weights	  to	  get	  the	  
final	   weights.	   Permutation	   test	   is	   used	   to	   get	   p-­‐values.	   Direction	   weights	   are	   re-­‐calculated	   after	   each	  
permutation.	  	  
#Depends	  on:	  	  
#Arguments:	  	   dat:	  data	  from	  Variant	  Tools.	  Require:	  (a)	  For	  phneotype,	  1s	  indicate	  cases;	  0s	  indicate	  controls.	  
(b)	  genotype	  scores	  are	  counts	  of	  the	  minor	  alleles	  (mutations).	  	  
#	   	   	   Yphenotype.name:	  Name	  of	  the	  phenotype	  
#	   	   	   testFunc:	  The	  name	  of	  the	  association	  test	  statistic	  calculating	  function	  
#	   	   	   weightScheme:	   "noWei":	   no	   weighting;	   "expWei":	   explicit	   weight	   only;	   "dirWei":	  
direction	  weight	  only;	  "expDirWei":	  explicit	  weights	  are	  multiplied	  b	  direction	  weights	  to	  get	  the	  final	  weights.	  
Default	   is	   no	   weighting.	   Variant	   Tools	   command	   must	   specify	   the	   expliciate	   weight	   for	   "expWei"	   and	  
"expDirWei";	  
#	   	   	   permuN:	  Number	  of	  the	  permutations	  
#Details:	  	  
#Value:	  Size	  of	  snp	  group;	  #	  of	  permutations;	  pvalue	  
#Note:	  	  	  








weightBurdenTest_invDir	   =	   function	   (dat,	   phenotype.name	   =	   "HTN",	   testFunc="LRTStat",	  
weightScheme="noWei",	  permuN	  =	  5000)	  {	  
	   	   	  
	   phenotypes	  =	  dat@Y[,phenotype.name];	  #phenotype	  
	   caseN	  =	  sum(phenotypes==1);	  
	   controlN	  =	  sum(phenotypes==0);	  
	   	  
	   genotypes	  =	  dat@X;	  #Genotype	  	  
	   genotypes[is.na(genotypes)]	  =	  0;	  #Missing	  genotype	  are	  treated	  as	  the	  major	  allele.	  	  
	   #genotypes=	  round(genotypes);	  
	   	  
	   #calculate	  direction	  weights	  based	  on	  genotypes	  and	  phenotypes	  
	   if	  (weightScheme	  %in%	  c("noWei",	  "dirWei"))	  	   	   weights	  =	  data.frame(rep(1,	  ncol(genotypes)));	  	  
#no	  weighting	  
	   if	  (weightScheme	  %in%	  c("expWei",	  "expDirWei"))	  	   weights	  =	  dat@V;	  	   	   	  
	   	   	   #explicit	  weights	  
	   if	  (weightScheme	  %in%	  c("dirWei",	  "expDirWei"))	  {	  
	   	   DirectionWeight	  =	  unlist(apply(genotypes,	  2,	  function(g)	  {	  
	   	   	   maf.case	  =	  sum(g[phenotypes==1])/(2*caseN);	  
	   	   	   maf.contr	  =	  sum(g[phenotypes==0])/(2*controlN);	  
	   	   	   #ifelse(maf.case	  >=	  maf.contr,	  1,	  -­‐1);	  #set	  up	  in	  weightBurdenTest.R	  
	   	   	   ifelse(maf.case	  >=	  maf.contr,	  -­‐1,	  1);	  
	   	   }));	  
	   	   weights	  =	  weights*DirectionWeight;	  
	   }	  
	  
	   #For	  real	  data	  
	   stat	  =	  do.call(testFunc,	  list(phenotypes,	  genotypes,	  weights,	  caseN,	  controlN));	  
	  
	   #For	  permutation	  test	  
	   stat.perms	  =	  0;	  
	   for	  (i	  in	  1:(permuN/10))	  {	  
	   	   pheno.perm	  =	  sample(phenotypes);	   	   	   	   	   	   	  
	   	   #Permutation	  stage	  1	  
	   	   if	  (weightScheme	  %in%	  c("noWei",	  "dirWei"))	  	   	   weights	   =	   data.frame(rep(1,	  
ncol(genotypes)));	  	  	  
	   	   if	  (weightScheme	  %in%	  c("expWei",	  "expDirWei"))	  	   weights	  =	  dat@V;	  	   	  
	   	   	   	   	  
	   	   if	  (weightScheme	  %in%	  c("dirWei",	  "expDirWei"))	  {	  
	   	   	   DirectionWeight	  =	  unlist(apply(genotypes,	  2,	  function(g)	  {	  
	   	   	   	   maf.case	  =	  sum(g[pheno.perm==1])/(2*caseN);	  
	   	   	   	   maf.contr	  =	  sum(g[pheno.perm==0])/(2*controlN);	  
	   	   	   	   #ifelse(maf.case	  >=	  maf.contr,	  1,	  -­‐1);	  #set	  up	  in	  weightBurdenTest.R	  
	   	   	   	   ifelse(maf.case	  >=	  maf.contr,	  -­‐1,	  1);	  
	   	   	   }));	  
	   	   	   weights	  =	  weights*DirectionWeight;	  
	   	   }	  
	   	   stat.perms[i]	  =	  do.call(testFunc,	  list(pheno.perm,	  genotypes,	  weights,	  caseN,	  controlN));	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   }	  
	   pValue	  =	  (sum(stat.perms	  >=	  stat)+0.5)/(length(stat.perms)+1);	  
	   if	  (pValue	  >	  0.1)	  {	  
	   	   return	  (list(geneSize=ncol(genotypes),	  permuN=i,	  pvalue=pValue));	  
	   }else	  {	  
	   	   for	  (i	  in	  (permuN/10+1):permuN)	  {	   	   	   	   	   	   	  
	   	   #Permutation	  stage	  2	  
	   	   	   pheno.perm	  =	  sample(phenotypes);	  
	   	   	   if	  (weightScheme	  %in%	  c("noWei",	  "dirWei"))	  	   	   weights	   =	   data.frame(rep(1,	  
ncol(genotypes)));	  	  	  
	   	   	   if	  (weightScheme	  %in%	  c("expWei",	  "expDirWei"))	  	   weights	  =	  dat@V;	  	  
	   	   	   	   	   	  
	   	   	   if	  (weightScheme	  %in%	  c("dirWei",	  "expDirWei"))	  {	  
	   	   	   	   DirectionWeight	  =	  unlist(apply(genotypes,	  2,	  function(g)	  {	  
	   	   	   	   	   maf.case	  =	  sum(g[pheno.perm==1])/(2*caseN);	  
	   	   	   	   	   maf.contr	  =	  sum(g[pheno.perm==0])/(2*controlN);	  
	   	   	   	   	   #ifelse(maf.case	  >=	  maf.contr,	  1,	  -­‐1);	  #set	  up	  in	  weightBurdenTest.R	  
	   	   	   	   	   ifelse(maf.case	  >=	  maf.contr,	  -­‐1,	  1);	  
	   	   	   	   }));	  
	   	   	   	   weights	  =	  weights*DirectionWeight;	  
	   	   	   }	  
	   	   	   stat.perms[i]	   =	   do.call(testFunc,	   list(pheno.perm,	   genotypes,	   weights,	   caseN,	  
controlN));	  
	   	   }	  
	   	   pValue	  =	  (sum(stat.perms	  >=	  stat)+0.5)/(length(stat.perms)+1);	  
	   	   return	  (list(geneSize=ncol(genotypes),	  permuN=i,	  pvalue=pValue));	  
	   }	  






	   #######################################################	  
	   #Description:	   Calculate	   the	   LRT	   statistic	   according	   to	  Bernoulli	   distribution.	   The	  burden	   score	   can	  be	  
weighted.	  The	  LRT	  statistic	  is	  gotten	  at	  the	  best	  burden	  score	  threshold	  that	  maximizes	  the	  statistic.	  	  
	   #Depends	  on:	  	  
	   #Arguments:	  phenotypes:	  A	  vector	  of	  binary	  phenotype	  values.	  Require:	  1s	  indicate	  cases;	  0s	  indicate	  
controls.	  	  
	   #	   	   	  	  	  genotypes:	  Genotype	  data	  frame	  (cols:	  variants;	  rows:	  sample	  subjects)	  
	   #	   	   	  	  	  weights:	  A	  one-­‐col	  data	  frame	  vector	  of	  variant	  weights	  wrt	  to	  genotypes.	  Default:	  all	  
1s	  (no	  weighting).	  
	   #	   	   	  	  	  caseN:	  Number	  of	  cases;	  
	   #	   	   	  	  	  controlN:	  Number	  of	  controls.	  	  
	   #Details:	  	  
	   #Value:	  LRT	  statistic	  
	   #Note:	  	  	  
	   #Author(s):	  ZWu,	  DZhang	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   #References:	  Chen,	  ...,	  Karchin	  2013	  PloS	  Paper	  
	   #See	  Also:	  
	   #Example:	  	  
	   #######################################################	  
	   LRTStat	   <-­‐	   function(phenotypes,	   genotypes,	   weights=data.frame(rep(1,	   ncol(genotypes))),	   caseN,	  
controlN)	  
	   {	  
	   	   burdenScores	  =	  data.matrix(genotypes)	  %*%	  data.matrix(weights);	   	  
	   	   	  
	   	   thresholds	  =	  c(unique(burdenScores),	  max(burdenScores)+1);	  
	   	   stats	  =	  array(0,	  dim=c(length(thresholds	  )));	  
	   	  
	   	   for	  (i	  in	  1:length(thresholds	  ))	  
	   	   {	  
	   	   	   Ys	  =	  (burdenScores	  >=	  thresholds[i]);	  
	   	   	   Ycase	  =	  sum(Ys[phenotypes==1]);	  
	   	   	   Ycontrol	  =	  sum(Ys[phenotypes==0]);	  
	   	   	   stats[i]	  =	  LRTStat.condi(Ycase,	  Ycontrol,	  caseN,	  controlN);	  
	   	   }	  
	   	   finalStat	  =	  max(stats[!is.na(stats)]);	  
	   	   return(finalStat);	  
	   }	  
	  
	  
	   #######################################################	  
	   #Description:	  Calculate	  the	  LRT	  statistic,	  conditional	  on	  given	  numbers	  of	  1's	  in	  cases	  and	  controls	  
	   #Depends	  on:	  	  
	   #Arguments:	  Ycase:	  number	  of	  1's	  in	  cases	  
	   #	   	   	  	  	  Ycontrol:	  number	  of	  1's	  in	  controls.	  
	   #	   	   	  	  	  caseN:	  Number	  of	  cases;	  
	   #	   	   	  	  	  controlN:	  Number	  of	  controls.	  	  
	   #Details:	  	  
	   #Value:	  LRT	  statistic	  
	   #Note:	  	  	  
	   #Author(s):	  ZWu,	  DZhang	  
	   #References:	  Chen,	  ...,	  Karchin	  2013	  PloS	  Paper	  
	   #See	  Also:	  
	   #Example:	  	  
	   #######################################################	  
	   LRTStat.condi	  <-­‐	  function(Ycase,	  Ycontrol,	  caseN,	  controlN)	  
	   {	  
	   	   pA	  =	  (Ycase	  +	  1)/(caseN	  +	  2);	  
	   	   pU	  =	  (Ycontrol	  +	  1)/(controlN	  +	  2);	  
	   	   p	  =	  (Ycase+	  Ycontrol	  +	  2)/(caseN+	  controlN+	  4);	  
	   	  
	   	   if	  (pA	  >=	  pU)	  
	   	   {	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   statistic	   =	   Ycase*log10(pA)+(caseN-­‐Ycase)*log10(1-­‐pA)+Ycontrol*log10(pU)+(controlN-­‐
Ycontrol)*log10(1-­‐pU)-­‐(Ycase+Ycontrol)*log10(p)-­‐(caseN+controlN-­‐Ycase-­‐Ycontrol)*log10(1-­‐p);	  
	   	   }	  
	   	   else	  
	   	   {	  
	   	   	   statistic	   =	   Ycase*log10(pU)+(caseN-­‐Ycase)*log10(1-­‐pU)+Ycontrol*log10(pA)+(controlN-­‐
Ycontrol)*log10(1-­‐pA)-­‐(Ycase+Ycontrol)*log10(p)-­‐(caseN+controlN-­‐Ycase-­‐Ycontrol)*log10(1-­‐p);	  
	   	  
	   	   }	  
	   	   return(statistic);	  









#Note	  this	  function	  give	  the	  inversed	  direction	  weight,	  contrasting	  to	  weightBurdenTest.R	  
#######################################################	  
#Description:	   Interface	   R	   function	   to	   be	   called	   by	   Variant	   Associate	   Tools.	   It	   has	   the	   choice	   to	   calculate	   an	  
association	  test	  statistic	  based	  on	  direction	  weighted	  burden	  score.	  That	  is,	  if	  MAF	  in	  cases	  <	  MAF	  in	  controls,	  
direction	  weight	  =	  1,	  o.w.,	  =-­‐1.	  Further	  explicit	  weights	  can	  be	  multiplied	  by	  these	  direction	  weights	  to	  get	  the	  
final	   weights.	   Permutation	   test	   is	   used	   to	   get	   p-­‐values.	   Direction	   weights	   are	   re-­‐calculated	   after	   each	  
permutation.	  	  
#Depends	  on:	  	  
#Arguments:	  	   dat:	  data	  from	  Variant	  Tools.	  Require:	  (a)	  For	  phneotype,	  1s	  indicate	  cases;	  0s	  indicate	  controls.	  
(b)	  genotype	  scores	  are	  counts	  of	  the	  minor	  alleles	  (mutations).	  	  
#	   	   	   Yphenotype.name:	  Name	  of	  the	  phenotype	  
#	   	   	   testFunc:	  The	  name	  of	  the	  association	  test	  statistic	  calculating	  function	  
#	   	   	   weightScheme:	   "noWei":	   no	   weighting;	   "expWei":	   explicit	   weight	   only;	   "dirWei":	  
direction	  weight	  only;	  "expDirWei":	  explicit	  weights	  are	  multiplied	  b	  direction	  weights	  to	  get	  the	  final	  weights.	  
Default	   is	   no	   weighting.	   Variant	   Tools	   command	   must	   specify	   the	   expliciate	   weight	   for	   "expWei"	   and	  
"expDirWei";	  
#	   	   	   permuN:	  Number	  of	  the	  permutations	  
#Details:	  	  
#Value:	  Size	  of	  snp	  group;	  #	  of	  permutations;	  pvalue	  
#Note:	  	  	  









weightBurdenTest_invDir_ToGetTypeIErrorCurve	   =	   function	   (dat,	   phenotype.name	   =	   "HTN",	  
testFunc="LRTStat",	  weightScheme="noWei",	  permuN	  =	  5000)	  {	  
	   	   	  
	  
	   phenotypes	  =	  dat@Y[,phenotype.name];	  #phenotype	  
	   pehnotypes	  =	  sample(phenotypes);	  	  ##To	  get	  type	  I	  error	  even	  for	  functional	  genes	  
	   	  
	   	  
	   	  
	   caseN	  =	  sum(phenotypes==1);	  
	   controlN	  =	  sum(phenotypes==0);	  
	   	  
	  
	   genotypes	  =	  dat@X;	  #Genotype	  	  
	   genotypes[is.na(genotypes)]	  =	  0;	  #Missing	  genotype	  are	  treated	  as	  the	  major	  allele.	  	  
	   #genotypes=	  round(genotypes);	  
	   	  
	   #calculate	  direction	  weights	  based	  on	  genotypes	  and	  phenotypes	  
	   if	  (weightScheme	  %in%	  c("noWei",	  "dirWei"))	  	   	   weights	  =	  data.frame(rep(1,	  ncol(genotypes)));	  	  
#no	  weighting	  
	   if	  (weightScheme	  %in%	  c("expWei",	  "expDirWei"))	  	   weights	  =	  dat@V;	  	   	   	  
	   	   	   #explicit	  weights	  
	   if	  (weightScheme	  %in%	  c("dirWei",	  "expDirWei"))	  {	  
	   	   DirectionWeight	  =	  unlist(apply(genotypes,	  2,	  function(g)	  {	  
	   	   	   maf.case	  =	  sum(g[phenotypes==1])/(2*caseN);	  
	   	   	   maf.contr	  =	  sum(g[phenotypes==0])/(2*controlN);	  
	   	   	   #ifelse(maf.case	  >=	  maf.contr,	  1,	  -­‐1);	  #set	  up	  in	  weightBurdenTest.R	  
	   	   	   ifelse(maf.case	  >=	  maf.contr,	  -­‐1,	  1);	  
	   	   }));	  
	   	   weights	  =	  weights*DirectionWeight;	  
	   }	  
	  
	  
	   #For	  real	  data	  
	  
	   stat	  =	  do.call(testFunc,	  list(phenotypes,	  genotypes,	  weights,	  caseN,	  controlN));	  
	  
	  
	   #For	  permutation	  test	  
	  
	   stat.perms	  =	  0;	  
	  
	   for	  (i	  in	  1:(permuN/10))	  {	  
	   	   pheno.perm	  =	  sample(phenotypes);	   	   	   	   	   	   	  
	   	   #Permutation	  stage	  1	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   if	  (weightScheme	  %in%	  c("noWei",	  "dirWei"))	  	   	   weights	   =	   data.frame(rep(1,	  
ncol(genotypes)));	  	  	  
	   	   if	  (weightScheme	  %in%	  c("expWei",	  "expDirWei"))	  	   weights	  =	  dat@V;	  	   	  
	   	   	   	   	  
	   	   if	  (weightScheme	  %in%	  c("dirWei",	  "expDirWei"))	  {	  
	   	   	   DirectionWeight	  =	  unlist(apply(genotypes,	  2,	  function(g)	  {	  
	   	   	   	   maf.case	  =	  sum(g[pheno.perm==1])/(2*caseN);	  
	   	   	   	   maf.contr	  =	  sum(g[pheno.perm==0])/(2*controlN);	  
	   	   	   	   #ifelse(maf.case	  >=	  maf.contr,	  1,	  -­‐1);	  #set	  up	  in	  weightBurdenTest.R	  
	   	   	   	   ifelse(maf.case	  >=	  maf.contr,	  -­‐1,	  1);	  
	   	   	   }));	  
	   	   	   weights	  =	  weights*DirectionWeight;	  
	   	   }	  
	   	   stat.perms[i]	  =	  do.call(testFunc,	  list(pheno.perm,	  genotypes,	  weights,	  caseN,	  controlN));	  
	  
	   }	  
	  
	   pValue	  =	  (sum(stat.perms	  >=	  stat)+0.5)/(length(stat.perms)+1);	  
	  
	   if	  (pValue	  >	  0.1)	  {	  
	  
	   	   return	  (list(geneSize=ncol(genotypes),	  permuN=i,	  pvalue=pValue));	  
	  
	   }else	  {	  
	  
	   	   for	  (i	  in	  (permuN/10+1):permuN)	  {	   	   	   	   	   	   	  
	   	   #Permutation	  stage	  2	  
	  
	   	   	   pheno.perm	  =	  sample(phenotypes);	  
	   	   	   if	  (weightScheme	  %in%	  c("noWei",	  "dirWei"))	  	   	   weights	   =	   data.frame(rep(1,	  
ncol(genotypes)));	  	  	  
	   	   	   if	  (weightScheme	  %in%	  c("expWei",	  "expDirWei"))	  	   weights	  =	  dat@V;	  	  
	   	   	   	   	   	  
	   	   	   if	  (weightScheme	  %in%	  c("dirWei",	  "expDirWei"))	  {	  
	   	   	   	   DirectionWeight	  =	  unlist(apply(genotypes,	  2,	  function(g)	  {	  
	   	   	   	   	   maf.case	  =	  sum(g[pheno.perm==1])/(2*caseN);	  
	   	   	   	   	   maf.contr	  =	  sum(g[pheno.perm==0])/(2*controlN);	  
	   	   	   	   	   #ifelse(maf.case	  >=	  maf.contr,	  1,	  -­‐1);	  #set	  up	  in	  weightBurdenTest.R	  
	   	   	   	   	   ifelse(maf.case	  >=	  maf.contr,	  -­‐1,	  1);	  
	   	   	   	   }));	  
	   	   	   	   weights	  =	  weights*DirectionWeight;	  
	   	   	   }	  
	   	   	   stat.perms[i]	   =	   do.call(testFunc,	   list(pheno.perm,	   genotypes,	   weights,	   caseN,	  
controlN));	  
	   	   }	  
	  




	   	   return	  (list(geneSize=ncol(genotypes),	  permuN=i,	  pvalue=pValue));	  
	  
	   }	  








	   #######################################################	  
	   #Description:	   Calculate	   the	   LRT	   statistic	   according	   to	  Bernoulli	   distribution.	   The	  burden	   score	   can	  be	  
weighted.	  The	  LRT	  statistic	  is	  gotten	  at	  the	  best	  burden	  score	  threshold	  that	  maximizes	  the	  statistic.	  	  
	   #Depends	  on:	  	  
	   #Arguments:	  phenotypes:	  A	  vector	  of	  binary	  phenotype	  values.	  Require:	  1s	  indicate	  cases;	  0s	  indicate	  
controls.	  	  
	   #	   	   	  	  	  genotypes:	  Genotype	  data	  frame	  (cols:	  variants;	  rows:	  sample	  subjects)	  
	   #	   	   	  	  	  weights:	  A	  one-­‐col	  data	  frame	  vector	  of	  variant	  weights	  wrt	  to	  genotypes.	  Default:	  all	  
1s	  (no	  weighting).	  
	   #	   	   	  	  	  caseN:	  Number	  of	  cases;	  
	   #	   	   	  	  	  controlN:	  Number	  of	  controls.	  	  
	   #Details:	  	  
	   #Value:	  LRT	  statistic	  
	   #Note:	  	  	  
	   #Author(s):	  ZWu,	  DZhang	  
	   #References:	  Chen,	  ...,	  Karchin	  2013	  PloS	  Paper	  
	   #See	  Also:	  
	   #Example:	  	  
	   #######################################################	  
	   LRTStat	   <-­‐	   function(phenotypes,	   genotypes,	   weights=data.frame(rep(1,	   ncol(genotypes))),	   caseN,	  
controlN)	  
	  
	   {	  
	  
	   	   burdenScores	  =	  data.matrix(genotypes)	  %*%	  data.matrix(weights);	   	  
	  
	   	   	  
	  
	   	   thresholds	  =	  c(unique(burdenScores),	  max(burdenScores)+1);	  
	  
	   	   stats	  =	  array(0,	  dim=c(length(thresholds	  )));	  
	  
	   	  
	  
	   	   for	  (i	  in	  1:length(thresholds	  ))	  
	  




	   	   	   Ys	  =	  (burdenScores	  >=	  thresholds[i]);	  
	  
	   	   	   Ycase	  =	  sum(Ys[phenotypes==1]);	  
	  
	   	   	   Ycontrol	  =	  sum(Ys[phenotypes==0]);	  
	  
	   	   	   stats[i]	  =	  LRTStat.condi(Ycase,	  Ycontrol,	  caseN,	  controlN);	  
	  
	   	   }	  
	  
	   	   finalStat	  =	  max(stats[!is.na(stats)]);	  
	  
	   	   return(finalStat);	  
	  




	   #######################################################	  
	   #Description:	  Calculate	  the	  LRT	  statistic,	  conditional	  on	  given	  numbers	  of	  1's	  in	  cases	  and	  controls	  
	   #Depends	  on:	  	  
	   #Arguments:	  Ycase:	  number	  of	  1's	  in	  cases	  
	   #	   	   	  	  	  Ycontrol:	  number	  of	  1's	  in	  controls.	  
	   #	   	   	  	  	  caseN:	  Number	  of	  cases;	  
	   #	   	   	  	  	  controlN:	  Number	  of	  controls.	  	  
	   #Details:	  	  
	   #Value:	  LRT	  statistic	  
	   #Note:	  	  	  
	   #Author(s):	  ZWu,	  DZhang	  
	   #References:	  Chen,	  ...,	  Karchin	  2013	  PloS	  Paper	  
	   #See	  Also:	  
	   #Example:	  	  
	   #######################################################	  
	  
	   LRTStat.condi	  <-­‐	  function(Ycase,	  Ycontrol,	  caseN,	  controlN)	  
	  
	   {	  
	  
	   	   pA	  =	  (Ycase	  +	  1)/(caseN	  +	  2);	  
	  
	   	   pU	  =	  (Ycontrol	  +	  1)/(controlN	  +	  2);	  
	  
	   	   p	  =	  (Ycase+	  Ycontrol	  +	  2)/(caseN+	  controlN+	  4);	  
	  
	   	  
	  




	   	   {	  
	  
	   	   	   statistic	   =	   Ycase*log10(pA)+(caseN-­‐Ycase)*log10(1-­‐pA)+Ycontrol*log10(pU)+(controlN-­‐
Ycontrol)*log10(1-­‐pU)-­‐(Ycase+Ycontrol)*log10(p)-­‐(caseN+controlN-­‐Ycase-­‐Ycontrol)*log10(1-­‐p);	  
	  
	   	   }	  
	  
	   	   else	  
	  
	   	   {	  
	  
	   	   	   statistic	   =	   Ycase*log10(pU)+(caseN-­‐Ycase)*log10(1-­‐pU)+Ycontrol*log10(pA)+(controlN-­‐
Ycontrol)*log10(1-­‐pA)-­‐(Ycase+Ycontrol)*log10(p)-­‐(caseN+controlN-­‐Ycase-­‐Ycontrol)*log10(1-­‐p);	  
	  
	   	  
	  
	   	   }	  
	  
	   	   return(statistic);	  
	  
	   }	  
	  
direct	  structure	  based	  prediction	  results	  of	  the	  effect	  of	  snv	  on	  PPI	  
P00533 P00533 EGFR EGFR A I 3b2u line8504 A 497 R->K Preserving 1 Neutral 0.97 
               
P00533 P00533 EGFR EGFR A B 3njp line8504 A 497 R->K Preserving 0.54 Detrimental 0.63 
               
P00749 Q03405 PLAU PLAUR A U 3bt2 line20283 U 198 K->R Preserving 0.9 Detrimental 0.47 
               
P01040 P01040 CSTA CSTA A B 1n9j line5181 A 96 T->M Preserving 0.79 Neutral 0.69 
               
P01040 P07711 CSTA CTSL D A 3kse line5181 D 96 T->M Preserving 1 Neutral 0.99 
               
P01040 P07858 CSTA CTSB C A 3k9m line5181 C 96 T->M Preserving 1 Neutral 0.76 
               
P01133 P00533 EGF EGFR B A 1nql line8504 A 497 R->K Preserving 0.92 Neutral 0.83 
               
P01343 P08833 IGF1 IGFBP1 C H 2dsq line8410 H 228 I->M #    
               
P02730 P02730 SLC4A1 SLC4A1 P Q 1hyn line17387 P 56 K->E Preserving 0.75 Neutral 0.6 
               
P06865 P07686 HEXA HEXB A B 2gk1 line15611 A 436 I->V #    
               
P09467 P09467 FBP1 FBP1 A B 3kbz line10359 A 217 R->K #    
               
P20591 P20591 MX1 MX1 A B 3ljb line21431 A 379 V->I Preserving 0.98 Neutral 0.97 
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P20827 P29317 EFNA1 EPHA2 B A 3mbw line2347 B 159 D->V #    
               
P29474 P29474 NOS3 NOS3 A B 1m9m line9663 A 297 D->E Preserving 0.86 Neutral 0.65 
               
P35228 P35228 NOS2 NOS2 A B 1nsi line16938 A 221 R->W Preserving 0.85 Detrimental 0.48 
               
P36404 Q9Y2Y0 ARL2 ARL2BP A B 3doe line12905 A 141 V->A Preserving 0.86 Neutral 0.92 
               
Q9H2X3 Q9H2X3 CLEC4M CLEC4M A B 1k9j line19024 A 291 D->N Preserving 0.99 Neutral 0.98 
	  
Hypertension  related  gene  list  (based  on  literature)  
ABCA3 ACSM3 ACVRL1 ADC ADD1 ADRA1A 
AGT AGTR1 ATP1B1 ATP2B1 BMPR2 CACNB2 
CAV1 CLCNKB CPS1 CSK CUL3 CYP11B1 
CYP11B2 CYP17A1 CYP3A5 ECE1 EDN3 FGF5 
GNAS GNB3 HFE HSD11B2 KCNJ1 KCNK3 
KCNMB1 KLHL3 LSP1 MADH9 MECOM MTHFR 
NOS2 NOS2A NOS3 NPR3 NR3C2 PLEKHA7 
PNMT PTGIS RET RETN RGS5 SARS2 
SCNN1B SCNN1G SDHA SDHAF2 SDHB SDHC 
SDHD SELE SH2B3 SLC12A1 SLC12A3 SMAD9 
SOX6 TBX3 TBX5 TNNT3 ULK4 UMOD 
VHL WNK1 WNK4 ZNF652   
	  
Hypertension  centered  network-­‐  interactions  from  HINT  databse  
A2M NOS3   NOS3 EFEMP2 
ACTB SMAD9   NOS3 EXOC6 
ACTN2 NOS3   NOS3 FIS1 
ACTN4 NOS3   NOS3 HTRA1 
ACVR1 BMPR2   NOS3 IMMT 
ACVR2A ACVRL1   NOS3 KANK2 
ACVRL1 ACVRL1   NOS3 MAST1 
ACVRL1 ENG   NOS3 MPRIP 
ACVRL1 TGFB1   NOS3 NOS3 
ACVRL1 TGFBR2   NOS3 PI4K2A 
ADD1 C1orf109   NOS3 PPP2R5A 
ADD1 CSNK2B   NOS3 RNF31 
ADD1 GEMIN7   NOS3 RNF32 
ADD1 HMG20A   NOS3 ST13 
ADD1 MAP1LC3B   NOS3 TXNDC11 
ADD1 PRKCD   NOS3 UMPS 
ADD1 SPTA1   NPPB NPR3 
ADD1 TK1   NPPC NPR3 
AES TBX3   NR3C2 EIF3I 
AGT ACE2   NR3C2 NCOA1 
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AGT AGT  NR3C2 PROX1 
AGT CTSG  NR3C2 PSMC5 
AGT EWSR1  NR3C2 SRC 
AGT GRB2  NR3C2 TRIM24 
AGT PRCP  OAZ3 ADC 
AGTR1 PDE6H  PICK1 PLEKHA7 
AGT REN  PLCG1 RET 
AKT1 NOS3  PNMT KLHL8 
AP2A1 SMAD9  PPL PLEKHA7 
ARHGDIA SDHC  PRKAR1A WNK1 
ARNT SMAD9  PRKAR1B WNK1 
ATP1B1 ATP1B1  RANBP9 WNK1 
ATP1B1 CRIP2  RAP1GAP2 WNK1 
ATP1B1 DDAH2  RASAL3 WNK1 
ATP1B1 EZH2  RET FRS2 
ATP1B1 LRIF1  RET NOTCH2NL 
ATP1B1 MLL4  RET RET 
ATP1B1 PSME1  RET SHC1 
ATP1B1 RIF1  RET SHC3 
ATP1B1 TRMT2A  RET STAT3 
ATP2B1 ATP2B1  SCNN1B NEDD4L 
ATP8 WNK1  SCNN1B STX1A 
ATXN1 WNK1  SCNN1B WWP2 
B2M HFE  SCNN1G NEDD4L 
BAD WNK1  SCNN1G STX1A 
BAG3 WNK1  SDHAF2 CCDC90B 
BDKRB2 NOS3  SDHAF2 SDHAF2 
BMP2 BMPR2  SDHB PIK3R5 
BMP4 BMPR2  SDHB SPRY2 
BMP7 BMPR2  SDHC SDHC 
BMPR2 BMPR2  SELE SELPLG 
BMPR2 GDF5  SH2B3 SH2B3 
BMPR2 MAPK8  SH2B3 USP32P1 
BMPR2 TGFBR1  SLC9A1 WNK1 
CA8 TBX3  SMAD2 SMAD9 
CACNB2 CTBP2  SMAD3 SMAD9 
CACNB2 HEXIM2  SMAD4 SMAD9 
CACNB2 PRKACA  SMAD9 ABTB1 
CAV1 CAV1  SMAD9 AFF1 
CAV1 CAV2  SMAD9 ARHGAP9 
CAV1 CSK  SMAD9 ARID1B 
CAV1 EGFR  SMAD9 ASB2 
CAV1 PLD1  SMAD9 ASH2L 
CAV1 PTPN1  SMAD9 BAZ1A 
CAV1 SRC  SMAD9 C10ORF2 
CAV1 TRAF2  SMAD9 CAMSAP1 
CBL RET  SMAD9 CEP135 
CCNDBP1 PLEKHA7  SMAD9 CHPF 
CENPJ WNK1  SMAD9 CLPB 
CHAF1A WNK1  SMAD9 CPXM2 
CLK2 ECE1  SMAD9 CSRP3 
CLTC WNK1  SMAD9 CTR9 
CNTN1 SCNN1B  SMAD9 CXXC5 
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COPS5 WNK1  SMAD9 DIAPH3 
CSDE1 WNK1  SMAD9 DKK1 
CSH1 SMAD9  SMAD9 DNAJA3 
CSK DOK3  SMAD9 DNAJC7 
CSK FGR  SMAD9 DSTN 
CSK FYN  SMAD9 EIF3C 
CSK KANK4  SMAD9 EIF3F 
CSK LCK  SMAD9 ERVV-1 
CSK PTPRB  SMAD9 EVC2 
CSK PTPRC  SMAD9 EXPH5 
CSK PTPRG  SMAD9 HEY1 
CSK PTPRJ  SMAD9 HEYL 
CSK PTPRK  SMAD9 HUWE1 
CSK PTPRO  SMAD9 KDM6A 
CSK PTPRZ1  SMAD9 KIAA0226 
CSK PXN  SMAD9 LEMD3 
CSK RGS16  SMAD9 LMO4 
CSK SHC1  SMAD9 MAN1A2 
CSK SRC  SMAD9 MAN1C1 
CSNK2B SDHA  SMAD9 MAN2B1 
CTBP1 MECOM  SMAD9 MBD1 
CUL3 ABTB1  SMAD9 MCM3AP 
CUL3 ABTB2  SMAD9 METAP1 
CUL3 BTBD6  SMAD9 MGAT1 
CUL3 GMCL1  SMAD9 MIA3 
CUL3 KCTD13  SMAD9 MLL2 
CUL3 KCTD6  SMAD9 MLL4 
CUL3 KCTD7  SMAD9 MOGAT1 
CUL3 KCTD9  SMAD9 MTCH1 
CUL3 KEAP1  SMAD9 MTMR10 
CUL3 KLHL12  SMAD9 MTMR11 
CUL3 KLHL2  SMAD9 NAGK 
CUL3 KLHL3  SMAD9 OTUB1 
CUL3 ZMAT4  SMAD9 PABPC4 
CYP11A1 SMAD9  SMAD9 PAPPA 
DOK1 RET  SMAD9 PELP1 
DST SMAD9  SMAD9 PHKA2 
E4F1 SMAD9  SMAD9 PIR 
ECE1 EDN1  SMAD9 PKP2 
ECE1 KRTAP10-
1 
 SMAD9 PLEC 
ECE1 KRTAP10-
3 
 SMAD9 PNPLA2 
ECE1 KRTAP10-
5 
 SMAD9 PPARD 
ECE1 KRTAP10-
8 
 SMAD9 PPP2R5E 
ECE1 KRTAP1-3  SMAD9 PSAP 
EDN3 EDNRB  SMAD9 PSMD8 
EEF1A1 SDHAF2  SMAD9 QARS 
EFEMP1 NOS3  SMAD9 RANBP9 
EGFR SH2B3  SMAD9 RFX1 
EIF3A WNK1  SMAD9 RMND5A 
EIF3E SMAD9  SMAD9 RNF123 
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ELAVL1 NOS3  SMAD9 RRBP1 
ELAVL3 NOS3  SMAD9 SECISBP2 
EPB41L2 WNK1  SMAD9 SF3B1 
EPRS SMAD9  SMAD9 SIL1 
ERBB2 SH2B3  SMAD9 SMAD9 
ERBB3 SH2B3  SMAD9 SMAP1 
ESR2 WNK4  SMAD9 SMG1 
EWSR1 KCNMB1  SMAD9 SNRNP70 
FAM13B WNK1  SMAD9 SPTBN1 
FAM53C WNK1  SMAD9 STAG1 
FAM65B WNK1  SMAD9 SVEP1 
FAM82A2 WNK1  SMAD9 TBCD 
FGF5 FGFR3  SMAD9 TERF1 
FHL3 WNK1  SMAD9 TINAGL1 
FHOD1 WNK1  SMAD9 TMEM57 
FLI1 SMAD9  SMAD9 TRIM29 
FLII SMAD9  SMAD9 TRIP12 
FLNA VHL  SMAD9 TTC37 
FLNC WNK1  SMAD9 UBA6 
FN1 SMAD9  SMAD9 UBE3A 
FN1 VHL  SMAD9 UBQLN1 
FTL SMAD9  SMAD9 UBQLN4 
GCDH NOS3  SMAD9 UNC45A 
GEM SDHB  SMAD9 VCPIP1 
GNB3 GNG3  SMAD9 VPS8 
GNB3 GNG4  SMAD9 XAB2 
GNB3 TGFBR1  SMAD9 YWHAQ 
GOLGA2 NOS3  SMAD9 ZEB2 
GPR25 RETN  SMAD9 ZNF484 
GRB2 SH2B3  SMAD9 ZNF557 
GRN SMAD9  SMAD9 ZNF587 
HDAC9 WNK1  SMAD9 ZNF592 
HFE HFE  SMAD9 ZNF8 
HFE TFR2  SMAD9 ZNF83 
HFE TFRC  SMAD9 ZSCAN4 
HIF1A VHL  SSFA2 WNK1 
HIVEP2 WNK1  STK39 WNK4 
HSP90AA1 NOS3  SYNPO WNK1 
IKBKAP SDHAF2  TBX3 PLEKHF2 
IMMT SDHAF2  TBX3 PRR20A 
KCNK3 YWHAB  TBX3 TOLLIP 
KCNK3 YWHAZ  TBX5 BAIAP2 
KEAP1 KLHL3  TBX5 ZMYND10 
KIAA0232 WNK1  TCEB1 VHL 
KLHL3 C6orf165  TCEB2 VHL 
KLHL3 KLHL12  TNFAIP1 CUL3 
KLHL3 KLHL3  TNFAIP3 WNK1 
LCK SH2B3  TNNI2 TNNT3 
LCP2 WNK1  TNNT3 HAP1 
LNPEP SMAD9  TNNT3 NUDT3 
LRMP WNK1  TNNT3 SNUPN 
LRP5 SMAD9  TNNT3 TNNT3 
MADD WNK1  TNNT3 TSG101 
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MAGEA11 NOS3  TNRC6A WNK1 
MAP2K1 WNK1  TNS1 WNK1 
MDFI VHL  TSC22D1 WNK1 
MECOM MECOM  ULK4 SMURF1 
MECOM SMAD3  VBP1 VHL 
MEOX2 RGS5  VHL CUL2 
MORF4L2 KLHL3  VHL ZNF512B 
MPHOSPH9 WNK1  WNK1 C5ORF25 
MSL2 WNK1  WNK1 CGNL1 
MTHFR NAA38  WNK1 SYNPO2 
MYH9 WNK1  WNK1 WNK1 
NEDD4L WNK1  WNK1 WNK2 
NEDD4 SCNN1B  WWTR1 WNK1 
NEDD4 SCNN1G  XRCC6 SDHC 
NEDD8 CUL3  YWHAE WNK1 
NOS2 NOS2  YWHAG WNK1 
NOS2 RAC1  YWHAZ WNK1 
NOS2 SLC9A3R1  ZFP106 WNK1 
NOS3 CDC37  ZNF839 WNK1 
   ZYX WNK1 
	  
Structurally  Resolved  Hypertension  Centered  Network  through	  INstruct  database  
BMP7 BMPR2  SMAD9 SMAD9 
NOS3 NOS3  FYN CSK 
SMAD3 SMAD9  ACVRL1 ACVRL1 
SH2B3 ERBB3  RET SHC1 
ACVRL1 ACVR2A  SMAD9 SMAD9 
SMAD9 SMAD2  SRC CSK 
ACVRL1 ACVR2A  SRC CSK 
SMAD9 SMAD4  SH2B3 SH2B3 
SMAD9 SMAD2  GNB3 GNG3 
PTPRB CSK  ACVRL1 ACVRL1 
NOS2 NOS2  STAT3 RET 
TFR2 HFE  SHC1 CSK 
SRC CSK  PLCG1 RET 
PTPRC CSK  RET RET 
FGR CSK  PTPRJ CSK 
NOS3 NOS3  PTPRB CSK 
CSK PTPRO  TGFBR1 BMPR2 
ACVR1 BMPR2  MECOM MECOM 
CSK PXN  SRC CSK 
HFE HFE  FYN CSK 
ATP2B1 ATP2B1  LCK CSK 
TCEB1 VHL  WNK1 WNK1 
SH2B3 GRB2  PTPRB CSK 
NPPC NPR3  ATP2B1 ATP2B1 
PTPRC CSK  TGFBR1 BMPR2 
FGF5 FGFR3  SRC CSK 
SDHAF2 SDHAF2  NOS2 NOS2 
BMP4 BMPR2  HFE HFE 
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ACVR1 BMPR2  NEDD8 CUL3 
NOS3 NOS3  NOS2 NOS2 
AGT CTSG  PTPRJ CSK 
FGR CSK  PTPRJ CSK 
GNB3 GNG4  PTPRG CSK 
RET RET  PTPRG CSK 
SRC CSK  TGFBR1 BMPR2 
HFE HFE  FGR CSK 
NOS2 NOS2  NOS2 NOS2 
FGR CSK  SRC CSK 
AGT AGT  PTPRZ1 CSK 
WNK1 PRKAR1B  FGR CSK 
PTPRZ1 CSK  LCK CSK 
FYN CSK  SH2B3 GRB2 
ATP1B1 ATP1B1  LCK CSK 
FYN CSK  ATP2B1 ATP2B1 
EGFR SH2B3  SH2B3 SH2B3 
BMP2 BMPR2  NOS3 NOS3 
LCK CSK  PTPRZ1 CSK 
FGR CSK  SHC1 CSK 
HFE TFRC  SRC CSK 
FYN CSK  FGR CSK 
FYN CSK  PTPRC CSK 
SRC CSK  FYN CSK 
NOS3 NOS3  WNK1 MAP2K1 
LCK CSK  BMPR2 BMPR2 
NOS3 NOS3  FYN CSK 
B2M HFE  SDHC SDHC 
SH2B3 LCK  ERBB2 SH2B3 
SH2B3 SH2B3  CSK PTPRO 
ACVRL1 ACVRL1  ATP2B1 ATP2B1 
PTPRG CSK  FGF5 FGFR3 
ATP2B1 ATP2B1  ATP2B1 ATP2B1 
TNNI2 TNNT3  SHC1 CSK 
ATP2B1 ATP2B1  ATP2B1 ATP2B1 
ACVRL1 ACVR2A  NOS2 NOS2 
NOS2 NOS2  LCK CSK 
B2M HFE  VHL HIF1A 
ACVR1 BMPR2  AGT REN 
SH2B3 LCK  NOS3 NOS3 
WNK1 PRKAR1A  WNK1 WNK2 
FGR CSK  WNK4 STK39 
LCK CSK  FGR CSK 
LCK CSK  SMAD9 SMAD4 
CSK PTPRO  MAPK8 BMPR2 
SH2B3 LCK  SMAD3 SMAD9 
PLCG1 RET  BMPR2 BMPR2 
LCK CSK  SH2B3 LCK 
TNNT3 TNNT3  SH2B3 GRB2 
SHC3 RET  FYN CSK 
   NPPB NPR3 
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